文献速递传染病防控与疫情报告卫生政策与健康促进

瑞士社会经济地位与COVID-19从检测到死亡的照护级联:基于人群的分析

Socioeconomic position and the COVID-19 care cascade from testing to mortality in Switzerland: a population-based analysis.
PubMed 文献 · Lancet Public Health · 2021-07-10

该研究分析瑞士2020年3月1日至2021年4月16日监测数据及2018年人口数据,以社区社会经济地位指数(Swiss-SEP)十分位分组,用负二项回归计算从检测到死亡各环节的发病率比。结果显示低社会经济地位社区检测更少但阳性率、住院、ICU和死亡风险更高,呈现明确的逆向照护规律。

要点

  • 关联在年轻年龄组更强,且地区间存在异质性。

核心结论

  • 瑞士COVID-19疫情中呈现逆向照护规律和社会经济不平等:低社会经济地位社区居民检测更少但阳性、住院和死亡风险更高。

研究设计与样本

  • 基于人群的监测数据分析,纳入2020年3月1日至2021年4月16日瑞士联邦公共卫生办公室报告数据及2018年人口数据。
  • 以Swiss-SEP指数(基于租金、教育、职业和拥挤度)将社区按十分位分为10组,用负二项回归计算调整后发病率比(aIRR)及95%可信区间。

主要发现

  • 分析基于4 129 636次检测、609 782次阳性检测、26 143次住院、2432次ICU入住、9383例死亡和8 221 406名居民。
  • 关联在年轻年龄组更强,且地区间存在异质性。

临床怎么用

  • 监测SARS-CoV-2检测、COVID-19疫苗接种可及性与接种率以及COVID-19结局时,应关注社会经济不平等。
  • 政府和卫生系统应采取减少健康不平等的措施以应对SARS-CoV-2大流行。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The inverse care law states that disadvantaged populations need more health care than advantaged populations but receive less. Gaps in COVID-19-related health care and infection control are not well understood. We aimed to examine inequalities in health in the care cascade from testing for SARS-CoV-2 to COVID-19-related hospitalisation, intensive care unit (ICU) admission, and death in Switzerland, a wealthy country strongly affected by the pandemic. METHODS: We analysed surveillance data reported to the Swiss Federal Office of Public Health from March 1, 2020, to April 16, 2021, and 2018 population data. We geocoded residential addresses of notifications to identify the Swiss neighbourhood index of socioeconomic position (Swiss-SEP). The index describes 1·27 million small neighbourhoods of approximately 50 households each on the basis of rent per m2, education and occupation of household heads, and crowding. We used negative binomial regression models to calculate incidence rate ratios (IRRs) with 95% credible intervals (CrIs) of the association between ten groups of the Swiss-SEP index defined by deciles (1=lowest, 10=highest) and outcomes. Models were adjusted for sex, age, canton, and wave of the epidemic (before or after June 8, 2020). We used three different denominators: the general population, the number of tests, and the number of positive tests. FINDINGS: Analyses were based on 4 129 636 tests, 609 782 positive tests, 26 143 hospitalisations, 2432 ICU admissions, 9383 deaths, and 8 221 406 residents. Comparing the highest with the lowest Swiss-SEP group and using the general population as the denominator, more tests were done among people living in neighbourhoods of highest SEP compared with lowest SEP (adjusted IRR 1·18 [95% CrI 1·02-1·36]). Among tested people, test positivity was lower (0·75 [0·69-0·81]) in neighbourhoods of highest SEP than of lowest SEP. Among people testing positive, the adjusted IRR was 0·68 (0·62-0·74) for hospitalisation, was 0·54 (0·43-0·70) for ICU admission, and 0·86 (0·76-0·99) for death. The associations between neighbourhood SEP and outcomes were stronger in younger age groups and we found heterogeneity between areas. INTERPRETATION: The inverse care law and socioeconomic inequalities were evident in Switzerland during the COVID-19 epidemic. People living in neighbourhoods of low SEP were less likely to be tested but more likely to test positive, be admitted to hospital, or die, compared with those in areas of high SEP. It is essential to continue to monitor testing for SARS-CoV-2, access and uptake of COVID-19 vaccination and outcomes of COVID-19. Governments and health-care systems should address this pandemic of inequality by taking measures to reduce health inequalities in response to the SARS-CoV-2 pandemic. FUNDING: Swiss Federal Office of Public Health, Swiss National Science Foundation, EU Horizon 2020, Branco Weiss Foundation.

来源:Lancet Public Health,查看原文。版权归原作者所有。

引用

  1. Riou J, Panczak R, Althaus CL, et al. Socioeconomic position and the COVID-19 care cascade from testing to mortality in Switzerland: a population-based analysis. Lancet Public Health. 2021. PMID: 34252364. doi:10.1016/S2468-2667(21)00160-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。